Showing 1461-1470 of 3966 results for "".
How Can Telemedicine Best Access the Inaccessible?
https://practicaldermatology.com/topics/practice-management/how-can-telemedicine-best-access-the-inaccessible/23954/Adam Friedman, MD, describes a new teledermatology program that brings care where it’s needed most.Practice Model: Outsourcing Administrative Work
https://practicaldermatology.com/topics/practice-management/practice-model-outsourcing-administrative-work/23921/Call centers, billing—which office tasks might be more efficiently handled outside your practice?Post-PHE Survival Guide for Dermatologists
https://practicaldermatology.com/topics/practice-management/post-phe-survival-guide-for-dermatologists/23914/Three things to know and do now that the PHE is over.Is a Good Faith Estimate Required for a Filler or Neuromodulator Treatment?
https://practicaldermatology.com/topics/practice-management/is-a-good-faith-estimate-required-for-a-filler-or-neuromodulator-treatment/23852/The latest updates from CMS do not specifically mention aesthetics in reference to good faith estimates, but there are indications that some aesthetic and dermatology services will require them. What about an appointment for injectables?A Dermatologist’s Guide to LinkedIn Marketing
https://practicaldermatology.com/topics/practice-management/a-dermatologists-guide-to-linkedin-marketing/23830/Understanding unique features of the social network allows practices to optimize their brand engagement.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-40/23808/Thanks and Best Wishes
https://practicaldermatology.com/series/editors-message/thanks-and-best-wishes/23807/Special Report: What I Did on My Summer Vacation
https://practicaldermatology.com/youngmd-connect/resident-resource-center/special-report-what-i-did-on-my-summer-vacation/23806/Spending time with kids at Camp Wonder changed the perspectives of these two residents.DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologyNew in My Practice: Devices/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-devicesnew-products-1/23772/